Scroll to page content
Big Pharma is running out the clock on American patients.
Stop the blame game. Stop the patent abuse. Stop the price hikes.
It’s time to beat the buzzer on Big Pharma’s blame game.
Drugmakers create life-saving treatments and breakthrough cures. But the problem is the price. Big Pharma alone controls their prices - and they alone can lower them for Americans today. Instead, they continue to raise prices year after year - even several times a year - making health care more expensive for everyone.
Now, Big Pharma is spending millions of dollars to shift the blame. This scheme helps pharmaceutical companies avoid accountability, undermine the bargaining power health insurance providers deliver for patients and keep medication prices high.
Americans deserve effective, market-based solutions that deliver real competition, create more choices and ensure that open and honest drug prices are driven by the value they bring to patients.
- $ 18.6 B
-
Pharmaceutical companies have earned more than $18.6 billion in revenues on new prescription drugs.
- 22 ¢
-
More than 22 cents of every premium dollar you pay goes into the pockets of Big Pharma.
- $ 3 M
-
A new generation of therapies cost patients as much as $3 million each year for treatment.
Over the past 20 years, pharmaceutical companies have earned more than $18.6 billion in total worldwide revenues on new prescription drugs that only cost them around $1.8 billion to develop. In fact, more than 22 cents of every premium dollar you pay goes into the pockets of Big Pharma to pay for prescription drugs—more than any other expense.
And costs keep rising. The Wall Street Journal recently reported on a new generation of therapies that cost patients as much as $3 million each year for treatment.
Health insurance providers are Americans’ bargaining power, negotiating for lower drug prices for them. When drug prices go down, you pay less. That’s why health insurance providers negotiate with drug companies for lower out-of-pocket costs and premiums for millions of patients. We’re not middlemen — we’re your bargaining power standing in the way of even higher drug prices.
We should not have to choose between innovation and affordability. With the right solutions, and genuine collaboration, we can have both.
Additional Resources
- Gaming the System: How Big Pharma Drives Its Higher Revenues Through Patent Gaming and Extending Exclusivity
- New Resource: How Boosting Biosimilar Medications Can Help Lower Drug Prices for Americans
- A Lump of Coal: Big Pharma's Patient Programs Are Clever Trappings for Higher Drug Prices
- Where Does Your Health Care Dollar Go?